TP53 and chronic lung disease: Particularly concerning an altered lung function with reduced lung remodeling and regeneration, and thus an increased susceptibility to acute and chronic lung diseases following lung (premature) aging, suggests targeting the p53-MDM2 interaction as an useful option to limit normal lung damage while preventing tumor cell proliferation and survival [44, 45].